tiprankstipranks
Beam Therapeutics Advances Base Editing Portfolio
PremiumCompany AnnouncementsBeam Therapeutics Advances Base Editing Portfolio
1M ago
Beam Therapeutics outlines key 2025 anticipated catalysts
Premium
The Fly
Beam Therapeutics outlines key 2025 anticipated catalysts
1M ago
Beam Therapeutics sees cash runway into 2027
Premium
The Fly
Beam Therapeutics sees cash runway into 2027
1M ago
Beam Therapeutics Advances BEAM-101 Therapy for Sickle Cell
PremiumCompany AnnouncementsBeam Therapeutics Advances BEAM-101 Therapy for Sickle Cell
2M ago
Beam presents new NHP data demonstrating proof-of-concept for ESCAPE
Premium
The Fly
Beam presents new NHP data demonstrating proof-of-concept for ESCAPE
2M ago
Beam Therapeutics announces new data from BEACON Phase 1/2 trial of BEAM-101
Premium
The Fly
Beam Therapeutics announces new data from BEACON Phase 1/2 trial of BEAM-101
3M ago
Beam Therapeutics management to meet virtually with Cantor Fitzgerald
PremiumThe FlyBeam Therapeutics management to meet virtually with Cantor Fitzgerald
3M ago
Beam Therapeutics participates in a conference call with JPMorgan
Premium
The Fly
Beam Therapeutics participates in a conference call with JPMorgan
3M ago
Beam Therapeutics upgraded to Outperform from Market Perform at Leerink
Premium
The Fly
Beam Therapeutics upgraded to Outperform from Market Perform at Leerink
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100